She Leads Biotech
Reimagining Rare Disease Drug Development with Nerissa Kreher In this episode of She Leads Biotech, I’m joined by Nerissa Kreher, Chief Medical Officer of Alltrna, for a conversation about rare disease innovation, precision medicine, and the future of drug development. With more than 20 years of experience in rare diseases, Nerissa shares her journey from pediatric endocrinologist to biotech executive and explains how Alltrna is taking a novel approach to treating genetic diseases through mutation-defined therapies. A fascinating discussion about science, innovation, leadership, and hope for families living with rare diseases. Chapters 00:00 Introduction 02:00 From Medicine to Biotech 05:00 Falling in Love with Rare Disease Research 08:00 Understanding Rare Disease Communities 12:00 The Challenge of Clinical Trials in Rare Diseases 16:00 Mutation-Defined Therapies Explained 21:00 How Alltrna Is Rethinking Drug Development 26:00 Regulatory & Clinical Development Challenges 31:00 Public vs Private Company Leadership 35:00 What Makes a Great Biotech Executive 39:00 Leadership, Mentorship & Authenticity 43:00 The Role of Patients in Drug Development 47:00 The Future of Rare Disease Innovation 51:00 Bringing Hope to Patients & Families #SheLeadsBiotech #RareDisease #PrecisionMedicine #GeneTherapy #BiotechLeadership #WomenInBiotech #CNAUSAExecutiveSearch
84 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de She Leads Biotech!